# FDA Inspection 1251751 - AMHWA Biopharm Co., Ltd - September 12, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/amhwa-biopharm-co-ltd/dced1bff-8944-4240-98c2-c0ffedbab9f7
Source feed: FDA_Inspections

> FDA Inspection 1251751 for AMHWA Biopharm Co., Ltd on September 12, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251751
- Company Name: AMHWA Biopharm Co., Ltd
- Inspection Date: 2024-09-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1251751 - 2024-09-12](https://www.globalkeysolutions.net/records/fda_inspections/amhwa-biopharm-co-ltd/12d05760-0d98-47cc-b961-3daa57f694ae)

Company: https://www.globalkeysolutions.net/companies/amhwa-biopharm-co-ltd/ea3bee5e-38bc-4803-9cb7-d137223a38bf

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c